The Ambient Light Multiple Myeloma Study

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 13, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Multiple Myeloma
Interventions
DEVICE

Circadian Effective Lighting

Participants will receive lighting with a spectrum of 300K, 500 lux to the eye level between 7:00am and 10:00am in the morning, and hospital lighting (\<100lux) during the afternoon between 10:00am and 6:00pm. In the evening this group of participants will receive lighting with a spectrum of 3000K, \<50lux at eye light level between 6:00PM and bedtime.

DEVICE

Circadian Ineffective Lightning (CIL)

Participants will receive lower lighting levels in the morning (lighting with A spectrum of 300k, \<50lux to the eye level between 7:00am and 10:00am) and the same lighting levels throughout the rest of the day.

Trial Locations (2)

10029

RECRUITING

Icahn Schoool of Medicine at Mount Sinai, New York

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER